TrialPharmacoEconomics2004

An economic evaluation of fluvastatin used for the prevention of cardiac events following successful first percutaneous coronary intervention in the UK.

Paul A Scuffham et al.PubMed ↗Publisher ↗

No numbers read from the abstract.